What Happens When You Stop Taking a GLP-1? (Weight Regain & How to Come Off)

The hardest truth about GLP-1 medications is also the most important one to understand before you start: for most people, stopping the drug means regaining a large share of the weight they lost. That's not a failure of willpower or a flaw in the medication — it's how obesity as a chronic condition behaves. This is a sourced look at what the trials actually show happens when people come off semaglutide or tirzepatide, why it happens, and how to think about tapering, maintenance, and the realistic long-term plan.

The evidence: what the trials show

The clearest data come from studies that deliberately stopped the drug. In the STEP-1 trial extension, participants who came off semaglutide (and its lifestyle support) regained about two-thirds of the weight they had lost within a year, and much of the cardiometabolic improvement reversed alongside the weight¹. STEP-4 tested the mirror image: people who reached the maintenance dose and then switched to placebo regained weight, while those who continued semaglutide kept losing — a roughly 17-percentage-point swing in favor of staying on². Tirzepatide behaves the same way. In SURMOUNT-4, people who stopped after the lead-in regained a substantial portion of their loss, while those who continued kept the weight off and lost a little more³. Across molecules, the signal is consistent: the weight loss largely persists while you take the drug and largely reverses when you don't.

Why the weight comes back

This isn't the drug "wearing off" in a mysterious way — it's biology reasserting itself. GLP-1 medications work by suppressing appetite and quieting the food-related signals that drive eating; when you remove them, appetite returns, and it often returns against a body that is metabolically defending its former higher weight. Reduced-obese bodies tend to run a lower metabolic rate and heightened hunger, a set of pressures that push weight back up unless something counteracts them. The medication was counteracting them. That's exactly why the FDA-approved labels frame these drugs as chronic treatments for a chronic condition, taken as an ongoing adjunct to diet and exercise rather than a short course⁵. Thinking of a GLP-1 like a course of antibiotics — take it, get better, stop — is the single most common mismatch between expectation and reality.

Does everyone regain everything?

No — the two-thirds figure is an average, not a verdict on any individual. Some people regain less, especially those who used the on-drug months to build durable habits: a consistent resistance-training routine, a genuinely higher-protein pattern of eating, better sleep, and portion norms that stick. Others regain most of it. What the data don't support is the hope that a few months on a GLP-1 permanently resets your weight; for the majority, some plan for maintenance is required to hold the loss. The habits you build while the drug makes eating less feel easy are the ones most likely to carry over — which is a strong argument for pairing the medication with real behavior change from day one, and for protecting muscle as you lose (see do GLP-1s cause muscle loss).

Tapering vs. stopping cold

If you and your clinician decide to come off, a gradual taper is generally gentler than an abrupt stop. Stepping the dose down rather than quitting outright can soften the return of appetite and give you a window to lean harder on the habits that hold weight in place. It also lets you watch how your hunger and weight respond and adjust the plan — sometimes the answer is to settle at a lower maintenance dose rather than stop entirely. There's no one-size taper; the point is that coming off is a managed transition to work through with a clinician, not a switch to flip. This is also where provider flexibility earns its keep: a program that can step you down, hold you at a lower dose, or restart smoothly if you regain is worth more than a cheaper one that only knows how to ship a full dose.

Building a maintenance plan

Whether you stay on a lower dose or come off entirely, maintenance is the real long game. The pillars are unglamorous and well-supported: keep protein high to preserve the muscle that supports your metabolism, keep resistance training in the week, protect sleep, and hold the eating patterns you built. Some people maintain on a reduced GLP-1 dose indefinitely; others taper off and hold with lifestyle alone; many land somewhere in between, cycling support as life changes. What matters is deciding in advance that the end of active weight loss is the start of maintenance, not the finish line. Our guide to choosing a provider for long-term use covers what to look for in a program you may lean on for years.

What this means for the provider you choose

Because a GLP-1 is usually a multi-year relationship rather than a one-time purchase, the provider decision is really a long-term one. Prioritize a program with a flexible dosing model, real clinician access to manage a taper or a maintenance dose, and an easy path to pause or restart — not just the lowest first-month price. You can weight those factors in the 2-minute quiz, compare real monthly pricing over 6 and 12 months in the cost calculator, and weigh the molecules in semaglutide vs. tirzepatide. If tirzepatide is your choice, our best tirzepatide providers board ranks the field.

The honest bottom line: stopping a GLP-1 usually brings back a large share of the weight, because the drug is treating an ongoing condition rather than curing it. That's not a reason to avoid these medications — the on-drug results are real and, in the trials, remarkably durable while treatment continues⁴. It's a reason to start with a realistic, long-term plan and a provider built to support it.